PRMT5 and central nervous system cancer: Chaturvedi et al. identified that PRMT5 interacted with and stabilized MYC in glioma [44], and Annarita et al. proposed that PRMT1 methylated c-Myc in the presence of PRMT5 in glioma stem cells [45].